Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Operating Income: 2019-2024

Historic Operating Income for Burning Rock Biotech (BNR) over the last 6 years, with Dec 2024 value amounting to -$49.0 million.

  • Burning Rock Biotech's Operating Income rose 483.73% to $20.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.5 million, marking a year-over-year decrease of 118.34%. This contributed to the annual value of -$49.0 million for FY2024, which is 48.04% up from last year.
  • As of FY2024, Burning Rock Biotech's Operating Income stood at -$49.0 million, which was up 48.04% from -$94.3 million recorded in FY2023.
  • Burning Rock Biotech's 5-year Operating Income high stood at -$49.0 million for FY2024, and its period low was -$142.1 million during FY2022.
  • Its 3-year average for Operating Income is -$95.1 million, with a median of -$94.3 million in 2023.
  • Its Operating Income has fluctuated over the past 5 years, first tumbled by 158.09% in 2020, then soared by 48.04% in 2024.
  • Over the past 5 years, Burning Rock Biotech's Operating Income (Yearly) stood at -$63.2 million in 2020, then crashed by 97.89% to -$125.1 million in 2021, then dropped by 13.65% to -$142.1 million in 2022, then soared by 33.68% to -$94.3 million in 2023, then soared by 48.04% to -$49.0 million in 2024.